Admin

Physician Resources Home

Profile for Bevacizumab with gemcitabine shows activity in phase ii pancreatic cancer trial

TitleBevacizumab with gemcitabine shows activity in phase ii pancreatic cancer trial
SpecialtyHematology/Oncology
SourceCMEWeb.com
Credits2
Credit TypeCategory 1
Cost20.00
Format
Description
  • Bevacizumab with Gemcitabine Shows Activity in Phase II Pancreatic Cancer Trial
  • Heparin-Induced Thrombocytopenia with Low Molecular Weight Heparin
  • Routine Surgical Staging in Grade 1 Endometrial Cancer Appears Beneficial
  • Randomized Trial First to Demonstrate a Survival Benefit in Patients with Recurrent Cervical Cancer
  • Proteomic Profiling in Ovarian Cancer: Is it Plausible?
  • ...
    ...read more at the CMEWeb.com website



    CME search results and details may not be correct. Please check with the source provider of the CME course for the most accurate list of CME course details, including cost, credits, format, availability and type.
    Copyright © 2005 - 2008 Medical Resource Group, LLC. All rights reserved.